Immune-Related Adverse Events: Pneumonitis.

Zhong, Linda; Altan, Mehmet; Shannon, Vickie R; Sheshadri, Ajay

Zhong, Linda; Altan, Mehmet; Shannon, Vickie R; Sheshadri, Ajay.

Affiliation

Zhong L; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shannon VR; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sheshadri A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. asheshadri@mdanderson.org.

Adv Exp Med Biol ; 1244: 255-269, 2020.

Article in En | MEDLINE | ID: mdl-32301020

Subject(s)

Immunotherapy/adverse effects; Neoplasms/therapy; Pneumonia/chemically induced; Pneumonia/immunology; Humans; Incidence; Neoplasms/immunology; Pneumonia/epidemiology; Pneumonia/therapy

Key words

Checkpoint inhibitors; Diffuse alveolar damage; Hypersensitivity pneumonitis; Immune-related adverse event; Nonspecific interstitial pneumonia; Organizing pneumonia; Pneumonitis; Thoracic imaging

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Immunotherapy / Neoplasms Type of study: Guideline / Incidence_studies / Prognostic_studies Limits: Humans Language: En Journal: Adv Exp Med Biol Year: 2020 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google